The treatment landscape for breast cancer is shifting rapidly, driven by the rise of antibody-drug conjugates (ADCs), a class of treatments that are designed to deliver potent che ...
A two-drug combination frequently used in anti-aging research causes brain damage in mice, University of Connecticut ...
TAMPA, Fla. — Doctors have been sounding the alarm for years that colorectal cancer is increasing at an alarming rate in people younger than 50. Now, legislation has been introduced at the federal ...
TAMPA, Fla. — Colorectal cancer is the leading cause of cancer deaths in people younger than 50, according to the American Cancer Society. Researchers at Moffitt Cancer Center in Tampa are working to ...
KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results